Ioannis N Mammas1, Maria Theodoridou2, Chryssie Koutsaftiki3, George Bertsias4, George Sourvinos5, Demetrios A Spandidos5. 1. Department of Clinical Virology, School of Medicine, University of Crete, Heraklion, Heraklion, Greece. Electronic address: mammasjo@googlemail.com. 2. First Department of Paediatrics, 'Aghia Sophia' Children's Hospital, University of Athens School of Medicine, Athens, Greece. 3. Paediatric Intensive Care Unit (PICU), 'Penteli' Children's Hospital, Penteli, Greece. 4. Department of Rheumatology, Clinical Immunology and Allergy, University Hospital of Heraklion, Heraklion, Greece. 5. Department of Clinical Virology, School of Medicine, University of Crete, Heraklion, Heraklion, Greece.
Abstract
STUDY OBJECTIVE: In this study we aimed to explore financial and other sociodemographic factors that affect nonvaccination against the human papillomavirus (HPV) in Greece, one of the first European Union countries to introduce the vaccination against HPV into its National Immunization Programme in 2008. DESIGN, SETTING, PARTICIPANTS, INTERVENTIONS, AND MAIN OUTCOME MEASURES: Six hundred thirty-two female adolescents (aged 11-16 years) from Greece completed a pilot cross-sectional questionnaire-based survey (ELEFTHERIA study) from 2008 to 2014. RESULTS: Overall, only 8.9% (56 of 632) of the female adolescents reported that they had received all 3 doses of the HPV vaccination. The HPV vaccination uptake rates increased gradually from 3.2% (3 of 95) in 2008 to 17.1% (14 of 82) in 2011. However, it abruptly decreased to 2.1% (2 of 95) in 2012 and it reached 9.2% (8 of 87) in 2013 and 11.5% (11 of 96) in 2014. The most common factors for nonvaccination included fear of side effects, which decreased (Spearman ρ = -0.860; P = .024) and financial issues, which increased statistically significantly (Spearman ρ = 0.890; P = .012) during the years 2008 to 2014. CONCLUSION: In our study we addressed the novel topic of the association of financial issues with HPV vaccination compliance and highlighted the urgent need to provide and maintain health insurance coverage to children in Greece, a country in financial crisis.
STUDY OBJECTIVE: In this study we aimed to explore financial and other sociodemographic factors that affect nonvaccination against the human papillomavirus (HPV) in Greece, one of the first European Union countries to introduce the vaccination against HPV into its National Immunization Programme in 2008. DESIGN, SETTING, PARTICIPANTS, INTERVENTIONS, AND MAIN OUTCOME MEASURES: Six hundred thirty-two female adolescents (aged 11-16 years) from Greece completed a pilot cross-sectional questionnaire-based survey (ELEFTHERIA study) from 2008 to 2014. RESULTS: Overall, only 8.9% (56 of 632) of the female adolescents reported that they had received all 3 doses of the HPV vaccination. The HPV vaccination uptake rates increased gradually from 3.2% (3 of 95) in 2008 to 17.1% (14 of 82) in 2011. However, it abruptly decreased to 2.1% (2 of 95) in 2012 and it reached 9.2% (8 of 87) in 2013 and 11.5% (11 of 96) in 2014. The most common factors for nonvaccination included fear of side effects, which decreased (Spearman ρ = -0.860; P = .024) and financial issues, which increased statistically significantly (Spearman ρ = 0.890; P = .012) during the years 2008 to 2014. CONCLUSION: In our study we addressed the novel topic of the association of financial issues with HPV vaccination compliance and highlighted the urgent need to provide and maintain health insurance coverage to children in Greece, a country in financial crisis.
Authors: A Kanellopoulou; I Giannakopoulos; S Fouzas; E Papachatzi; S Nasikas; A Papakonstantinopoulou; G Dimitriou; D Gkentzi Journal: Hum Vaccin Immunother Date: 2021-09-02 Impact factor: 4.526
Authors: Ioannis N Mammas; Tina Dalianis; Sotiros G Doukas; Apostolos Zaravinos; Vassilis Achtsidis; Prakash Thiagarajan; Maria Theodoridou; Demetrios A Spandidos Journal: Exp Ther Med Date: 2019-04-22 Impact factor: 2.447
Authors: Ioannis Thanasas; Giagkos Lavranos; Pinelopi Gkogkou; Dimitrios Paraskevis Journal: Int J Environ Res Public Health Date: 2022-01-03 Impact factor: 3.390